CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 133 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2020. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $180,830 | +60.1% | 21,553 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $112,938 | -3.5% | 21,553 | +0.6% | 0.00% | 0.0% |
| Q4 2019 | $116,975 | +48.4% | 21,424 | +32.3% | 0.00% | +100.0% |
| Q3 2019 | $78,850 | -36.6% | 16,191 | -9.8% | 0.00% | -50.0% |
| Q2 2019 | $124,449 | +21.5% | 17,958 | +21.8% | 0.00% | 0.0% |
| Q1 2019 | $102,450 | +3.4% | 14,741 | -13.2% | 0.00% | 0.0% |
| Q4 2018 | $99,122 | -22.6% | 16,973 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $128,146 | -99.9% | 16,973 | 0.0% | 0.00% | +100.0% |
| Q2 2018 | $85,713,000 | -17.2% | 16,973 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $103,536,000 | +100420.4% | 16,973 | +16.7% | 0.00% | 0.0% |
| Q4 2017 | $103,000 | -56.7% | 14,550 | -56.3% | 0.00% | 0.0% |
| Q3 2017 | $238,000 | +12.8% | 33,287 | -0.6% | 0.00% | 0.0% |
| Q2 2017 | $211,000 | – | 33,480 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $1,273,000 | 0.73% |
| ETF MANAGERS GROUP, LLC | 7,062,485 | $1,787,000 | 0.05% |
| Ikarian Capital, LLC | 862,527 | $217,000 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 457,209 | $115,000 | 0.02% |
| Platform Technology Partners | 33,750 | $9,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 910,006 | $230,000 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $7,683 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,029,171 | $1,016,000 | 0.00% |
| Vident Investment Advisory, LLC | 267,612 | $67,000 | 0.00% |
| Aries Wealth Management | 15,400 | $4,000 | 0.00% |